Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3

Journal of Virology

Volumn 85, Issue 21, 2011, Pages 11079-11089

  Zhu, Huifang ^a   Zheng, Chunfu ^a   Xing, Junji ^a   Wang, Shuai ^a   Li, Shuping ^b   Lin, Rongtuan ^c   Mossman, Karen L ^d  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c MCGILL UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN ORF61; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE; GENE ACTIVITY; HERPES ZOSTER; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPRECIPITATION; IMMUNOSTIMULATION; INNATE IMMUNITY; INTERFERON STIMULATED RESPONSE ELEMENT; ISG54 GENE; ISG56 GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENDAI VIRUS; TRANSCRIPTION INITIATION; UBIQUITINATION; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION; VIRUS GENE; WESTERN BLOTTING;

HUMAN HERPESVIRUS 3; SENDAI VIRUS;

EID: 80055115107     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05098-11     Document Type: Article

References (60)

1. Ambagala, A. P., and J. I. Cohen. 2007. Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response. J. Virol. 81:7844-7851.
2. Arvin, A. M. 1996. Immune responses to varicella-zoster virus. Infect. Dis. Clin. North Am. 10:529-570.
3. Arvin, A. M. 2001. Varicella-zoster virus: molecular virology and virus-host interactions. Curr. Opin. Microbiol. 4:442-449.
4. Balachandra, K., et al. 1994. Effects of human alpha, beta and gamma interferons on varicella zoster virus in vitro. Southeast Asian J. Trop. Med. Public Health 25:252-257.
5. Barro, M., and J. T. Patton. 2005. Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3. Proc. Natl. Acad. Sci. U. S. A. 102:4114-4119.
6. Cassady, K. A., and M. Gross. 2002. The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J. Virol. 76:2029-2035.
7. Chang, T. H., C. L. Liao, and Y. L. Lin. 2006. Flavivirus induces interferonbeta gene expression through a pathway involving RIG-I-dependent IRF3 and PI3K-dependent NF-κB activation. Microbes Infect. 8:157-171.
8. Clement, J. F., et al. 2008. Phosphorylation of IRF3 on Ser 339 generates a hyperactive form of IRF3 through regulation of dimerization and CBP association. J. Virol. 82:3984-3996.
9. Desloges, N., M. Rahaus, and M. H. Wolff. 2005. Role of the protein kinase PKR in the inhibition of varicella-zoster virus replication by beta interferon and gamma interferon. J. Gen. Virol. 86:1-6.
10. Devaraj, S. G., et al. 2007. Regulation of IRF3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 282:32208-32221.
11. Ehrhardt, C., et al. 2004. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. FEBS Lett. 567:230-238.
12. Everett, R. D. 1984. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3:3135-3141.
13. Everett, R. D., et al. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80:7995-8005. 13a.
14. Everett, R. D., and A. Orr. 2009. Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction. J. Virol. 83:4978-4983.
15. Gelman, I. H., and S. Silverstein. 1985. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 82:5265-5269.
16. Hartman, A. L., et al. 2008. Inhibition of IRF3 activation by VP35 is critical for the high level of virulence of Ebola virus. J. Virol. 82:2699-2704.
17. Inchauspe, G., S. Nagpal, and J. M. Ostrove. 1989. Mapping of two varicellazoster virus-encoded genes that activate the expression of viral early and late genes. Virology 173:700-709.
18. Jordan, M., A. Schallhorn, and F. M. Wurm. 1996. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:596-601.
19. Kim, J. C., et al. 2008. HSV-1 ICP27 suppresses NF-κB activity by stabilizing IκBα. FEBS Lett. 582:2371-2376.
20. Kochs, G., A. Garcia-Sastre, and L. Martinez-Sobrido. 2007. Multiple antiinterferon actions of the influenza A virus NS1 protein. J. Virol. 81:7011-7021.
21. Ku, C. C., et al. 2004. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J. Exp. Med. 200:917-925.
22. Lin, R., C. Heylbroeck, P. M. Pitha, and J. Hiscott. 1998. Virus-dependent phosphorylation of the IRF3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
23. Lin, R., et al. 2006. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKK∑ molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80:6072-6083.
24. Lin, R., R. S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. 2004. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J. Virol. 78:1675-1684.
25. Lin, R., et al. 2006. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281:2095-2103.
26. Magnani, M., R. Crinelli, M. Bianchi, and A. Antonelli. 2000. The ubiquitindependent proteolytic system and other potential targets for the modulation of nuclear factor-κB (NF-κB). Curr. Drug Targets 1:387-399.
27. Melroe, G. T., L. Silva, P. A. Schaffer, and D. M. Knipe. 2007. Recruitment of activated IRF3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: potential role in blocking IFN-beta induction. Virology 360:305-321. 26a.
28. Melroe, G. T., N. A. DeLuca, and D. M. Knipe. 2004. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J. Virol. 78:8411-8420.
29. Mikloska, Z., A. M. Kesson, M. E. Penfold, and A. L. Cunningham. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J. Infect. Dis. 173:7-17.
30. Moriuchi, H., M. Moriuchi, H. A. Smith, S. E. Straus, and J. I. Cohen. 1992. Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J. Virol. 66:7303-7308.
31. Mueller, N. H., D. H. Gilden, R. J. Cohrs, R. Mahalingam, and M. A. Nagel. 2008. Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol. Clin. 26:675-697.
32. Muller, U., et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
33. Nagpal, S., and J. M. Ostrove. 1991. Characterization of a potent varicellazoster virus-encoded trans-repressor. J. Virol. 65:5289-5296.
34. Otani, N., K. Baba, and T. Okuno. 2009. Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity. J. Immunol. Methods 351:71-74.
35. Paladino, P., S. E. Collins, and K. L. Mossman. 2010. Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses. PLoS One 5:e10428.
36. Paladino, P., and K. L. Mossman. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29:599-607.
37. Pan, W., X. Ren, H. Guo, Q. Ding, and A. C. Zheng. 2010. Expression, purification of herpes simplex virus type 1 UL4 protein, and production and characterization of UL4 polyclonal antibody. J. Virol. Methods 163:465-469.
38. Paz, S., et al. 2009. Ubiquitin-regulated recruitment of IκB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29:3401-3412.
39. Reichelt, M., J. Brady, and A. M. Arvin. 2009. The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J. Virol. 83: 3904-3918.
40. Sadler, A. J., and B. R. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
41. Saira, K., Y. Zhou, and C. Jones. 2007. The infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta interferon promoter activity. J. Virol. 81:3077-3086.
42. Sen, N., et al. 2010. Varicella-zoster virus immediate-early protein 62 blocks interferon regulatory factor 3 (IRF3) phosphorylation at key serine residues: a novel mechanism of IRF3 inhibition among herpesviruses. J. Virol. 84: 9240-9253.
43. Servant, M. J., N. Grandvaux, and J. Hiscott. 2002. Multiple signaling pathways leading to the activation of interferon regulatory factor 3. Biochem. Pharmacol. 64:985-992.
44. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKKrelated pathway. Science 300:1148-1151.
45. Shibaki, T., T. Suzutani, I. Yoshida, M. Ogasawara, and M. Azuma. 2001. Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type 1. J. Interferon Cytokine Res. 21:279-285.
46. Smith, E. J., I. Marie, A. Prakash, A. Garcia-Sastre, and D. E. Levy. 2001. IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Iκ B kinase but is blocked by Vaccinia virus E3L protein. J. Biol. Chem. 276:8951-8957.
47. Stevenson, D., K. L. Colman, and A. J. Davison. 1992. Characterization of the varicella-zoster virus gene 61 protein. J. Gen. Virol. 73(Pt. 3):521-530.
48. Suzutani, T., et al. 2000. The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection. J. Gen. Virol. 81:1763-1771.
49. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
50. Vandevenne, P., et al. 2011. The varicella-zoster virus ORF47 kinase interferes with host innate immune response by inhibiting the activation of IRF3. PLoS One 6:e16870.
51. Walters, M. S., C. A. Kyratsous, and S. J. Silverstein. 2010. The RING finger domain of Varicella-Zoster virus ORF61p has E3 ubiquitin ligase activity that is essential for efficient autoubiquitination and dispersion of Sp100-containing nuclear bodies. J. Virol. 84:6861-6865.
52. Xing, J., et al. 2011. Comprehensive characterization of interaction complexes of herpes simplex virus type 1 ICP22, UL3, UL4, and UL20.5. J. Virol. 85:1881-1886.
53. Xing, J., F. Wu, W. Pan, and C. Zheng. 2010. Molecular anatomy of subcellular localization of HSV-1 tegument protein US11 in living cells. Virus Res. 153:71-81.
54. Yoneyama, M., et al. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737.
55. Zhang, B., et al. 2009. The TAK1-JNK cascade is required for IRF3 function in the innate immune response. Cell Res. 19:412-428.
56. Zhang, C., et al. 2008. A conserved domain of herpes simplex virus ICP34.5 regulates protein phosphatase complex in mammalian cells. FEBS Lett. 582:171-176.
57. Zhang, Z., et al. 2007. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 81:9024-9033.
58. Zhao, T., et al. 2007. The NEMO adaptor bridges the nuclear factor-_B and interferon regulatory factor signaling pathways. Nat. Immunol. 8:592-600.
59. Zhong, B., et al. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29:538-550.
60. Zhu, H., and Zheng, C. 2011. Varicella zoster virus immediate early protein 61 blocks the IFN-β pathway by degradation the activited [sic] IRF3. BMC Proc. 5(Suppl. 1):P99.